JAY M ENOCH
Optometry at Shuey Dr, Moraga, CA
License number
Florida 1213
Effective Date
Jan 1, 1901
Expiration Date
Feb 28, 1997
Category
Health Care
Type
Optometrist
Address
Address
54 Shuey Dr, Moraga, CA 94556
Professional information
Hyperacuity Testing Instrument For Evaluating Visual Function
US Patent:
4765732, Aug 23, 1988
Filed:
Mar 20, 1987
Appl. No.:
7/028711
Inventors:
Jay M. Enoch - Moraga CA
Assignee:
The Regents of the University of California - Berkeley CA
International Classification:
A61B 302
US Classification:
351243
Abstract:
A hyperacuity testing instrument is adapted to evaluate visual function by selectively changing the relative position of two spots or points of light that function as visual stimuli for observation by a patient. The instrument includes a laser that emits a single beam of light that is split into two beams when it passes through a bi-prism. The beams of light are visually shown as two spots on a display screen for recorded perception by a patient. A rotary adjustment selectively varies the rotational positions of the spots relative to each other whereas a linear adjustment selectively varies the separation gap between the spots. The recorded data enables a surgeon to determine whether corrective surgery to remove an ocular media opacity will, in fact, improve vision, i. e. , the test procedure "penetrates" the opacity to assess visual function at the retinal-neural level.
Method For Evaluating Metamorphopsia
US Patent:
4798456, Jan 17, 1989
Filed:
Mar 23, 1987
Appl. No.:
7/029313
Inventors:
Jay M. Enoch - Moraga CA
Richard A. Knowles - Berkeley CA
Richard A. Knowles - Berkeley CA
Assignee:
The Regents of the University of California - Berkeley CA
International Classification:
A61B 302
US Classification:
351222
Abstract:
A hyperacuity testing method is suitably programmed for quantitatively measuring metamorphopsia of a patient's visual system, detecting and measuring metamorphopsia behind a media opacity, such as cataract, and detecting and measuring smaller amounts of metamorphopsia and other visual distortions than previously possible. The method comprises displaying at least two spaced and fixed first spots on a screen, along with a movable second spot. A patient is instructed to selectively move the second spot relative to the fixed first spots whereby the clinician is enabled to comparatively record separation distances and displacement of the second spot relative to the first spots.